CXCR4 and infection: This dimer was described to have potent anti-HIV-1 activity due to inhibition of infection with R5-tropic HIV-1 SF162 and CXCR4-tropic HIV-1 NL4-3 in TZM-bl cells, with an IC50 of 0.36 and 0.26 μM, respectively (164).